Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Clearside enrolls first patient in phase III trial of Zuprata combination therapy
Clearside enrolls first patient in phase III trial of Zuprata combination therapy
Clearside enrolls first patient in phase III trial of Zuprata combination therapy
Submitted by
admin
on February 20, 2017 - 9:53am
Source:
Drug Delivery Business News
News Tags:
Clearside Biomedical
Zuprata
Eylea
retinal vein occulsion
Headline:
Clearside enrolls first patient in phase III trial of Zuprata combination therapy
Do Not Allow Advertisers to Use My Personal information